As shown in Fig. 5b, the tumor regression effect of docetaxel was significantly higher in mice injected with FSIP1 knockout breast cancer cell, indicating that FSIP1 mediates docetaxel resistance. The gene discussed is FSIP1; the disease is neoplasm.